Caricamento...
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
The HER2-positive breast cancer subtype (HER2(+)-BC) displays a particularly aggressive behavior. Anti-HER2 therapies have significantly improved the survival of patients with HER2(+)-BC. However, a large number of patients become refractory to current targeted therapies, necessitating the developme...
Salvato in:
| Pubblicato in: | Cell Death Dis |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7568723/ https://ncbi.nlm.nih.gov/pubmed/33070155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03081-w |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|